Primary CNS Lymphoma
2 competing products in clinical development for Primary CNS Lymphoma.
Pipeline by Phase
Phase 22
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Rituximab + Methotrexate + Cytarabine Injection | Celltrion | Phase 2 | UNKNOWN | 52 |
| Rituximab, lenalidomide | Celltrion | Phase 2 | Recruiting | 52 |